Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo—Controlled Trial

The purpose of this study is to evaluate the effects of botulinum toxin type A (BoNT-A) for managing sleep bruxism (SB) in a randomized, placebo-controlled trial. Thirty SB subjects were randomly assigned into two groups evenly. The placebo group received saline injections into each masseter muscle,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Young Joo, Lee, Hee Jin, Park, Keun Jeong, Kim, Hyung Tack, Hong, Il Hee, Kim, Seong Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150956/
https://www.ncbi.nlm.nih.gov/pubmed/32182879
http://dx.doi.org/10.3390/toxins12030168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150956/
https://www.ncbi.nlm.nih.gov/pubmed/32182879
http://dx.doi.org/10.3390/toxins12030168

Ejemplares similares